These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2144431)

  • 101. Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors.
    Petersen I; Baatrup G; Jepsen HH; Svehag SE
    Complement; 1985; 2(2-3):97-110. PubMed ID: 2935361
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35).
    Hebert LA; Birmingham DJ; Dillon JJ; Cosio FG; Shen XP
    J Am Soc Nephrol; 1994 Apr; 4(10):1786-91. PubMed ID: 8068876
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Another function of erythrocytes: transport of circulating immune complexes.
    Pascual M; Schifferli JA
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The quantification of C3 fragments on erythrocytes: estimation of C3 fragments on normal cells, acquired haemolytic anaemia cases and correlation with agglutination of sensitized cells.
    Merry AH; Thomson EE; Rawlinson VI; Stratton F
    Clin Lab Haematol; 1983; 5(4):387-97. PubMed ID: 6607814
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.
    Lindorfer MA; Hahn CS; Foley PL; Taylor RP
    Immunol Rev; 2001 Oct; 183():10-24. PubMed ID: 11782244
    [TBL] [Abstract][Full Text] [Related]  

  • 107. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.
    Odera M; Otieno W; Adhiambo C; Stoute JA
    Clin Exp Immunol; 2011 Nov; 166(2):201-7. PubMed ID: 21985366
    [TBL] [Abstract][Full Text] [Related]  

  • 110. CR1 and CR1-like: the primate immune adherence receptors.
    Birmingham DJ; Hebert LA
    Immunol Rev; 2001 Apr; 180():100-11. PubMed ID: 11414352
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.
    Salam KA; Wang RY; Grandinetti T; De Giorgi V; Alter HJ; Allison RD
    Hepatology; 2018 Dec; 68(6):2118-2129. PubMed ID: 29742812
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups.
    Moulds JM; Reveille JD; Arnett FC
    Clin Exp Immunol; 1996 Aug; 105(2):302-5. PubMed ID: 8706338
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Kisserli A; Fure H; Dahl JA; Donvito B; Reveil B; Ludviksen JK; Tabary T; Mollnes TE; Cohen JHM
    Mol Immunol; 2019 Oct; 114():139-148. PubMed ID: 31352230
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.
    Swaak AJ; Hannema A; Vogelaar C; Boom FA; van Es L; van Aalst R; Statius van Eps LW
    Rheumatol Int; 1982; 2(4):161-6. PubMed ID: 6984977
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
    Anand D; Kumar U; Kanjilal M; Kaur S; Das N
    Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
    Krauledat PB; Krapf FE; Manger B; Kalden JR
    Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients.
    Baatrup G; Petersen I; Kappelgaard E; Jepsen HH; Svehag SE
    Clin Exp Immunol; 1984 Feb; 55(2):313-8. PubMed ID: 6230182
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
    Kulik L; Laskowski J; Renner B; Woolaver R; Zhang L; Lyubchenko T; You Z; Thurman JM; Holers VM
    J Immunol; 2019 Dec; 203(12):3136-3147. PubMed ID: 31732528
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
    Swaak AJ; Groenwold J; Hannema A; Hack CE
    Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
    [TBL] [Abstract][Full Text] [Related]  

  • 120. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.
    Wilson JG; Andriopoulos NA; Fearon DT
    Immunol Res; 1987; 6(3):192-209. PubMed ID: 2960763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.